1. Home
  2. NTHI vs BWEN Comparison

NTHI vs BWEN Comparison

Compare NTHI & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$3.35

Market Cap

106.0M

Sector

Health Care

ML Signal

HOLD

Logo Broadwind Inc.

BWEN

Broadwind Inc.

HOLD

Current Price

$4.26

Market Cap

105.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTHI
BWEN
Founded
2008
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
106.0M
105.5M
IPO Year
2023
2009

Fundamental Metrics

Financial Performance
Metric
NTHI
BWEN
Price
$3.35
$4.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
★ $15.00
$6.00
AVG Volume (30 Days)
179.9K
★ 201.7K
Earning Date
05-19-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 360.00
EPS
N/A
★ N/A
Revenue
$39,990.00
★ $146,785,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$17.37
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.96
$1.88
52 Week High
$12.99
$5.70

Technical Indicators

Market Signals
Indicator
NTHI
BWEN
Relative Strength Index (RSI) 41.18 49.26
Support Level $3.03 $4.10
Resistance Level $3.70 $4.89
Average True Range (ATR) 0.42 0.17
MACD -0.06 0.04
Stochastic Oscillator 15.74 74.60

Price Performance

Historical Comparison
NTHI
BWEN

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. The company provides technologically high-value products to customers with complex systems and stringent quality standards that operate in the energy, mining, and infrastructure sectors in the United States of America. Its capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treatment, CNG decompression, precision machining, assembly, engineering, and packaging solutions, among others. The company operates in four reportable segments: Heavy Fabrications, which generates the maximum revenue, Gearing, Industrial Solutions, and Corporate.

Share on Social Networks: